Ryuichi Tsujita
Chiyoda, 1018101, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Role of high-mobility group box 1 and its modulation by thrombomodulin/thrombin axis in neuropathic and inflammatory pain.
Journal: British journal of pharmacology
Published: February 06, 2020
Thrombomodulin alfa prevents oxaliplatin-induced neuropathic symptoms through activation of thrombin-activatable fibrinolysis inhibitor and protein C without affecting anti-tumor activity.
Journal: European journal of pharmacology
Published: January 16, 2020
HMGB1 as a target for prevention of chemotherapy-induced peripheral neuropathy
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Published: November 19, 2019
Thrombomodulin induces anti-inflammatory effects by inhibiting the rolling adhesion of leukocytes in vivo.
Journal: Journal of pharmacological sciences
Published: June 09, 2019
Human soluble thrombomodulin-induced blockade of peripheral HMGB1-dependent allodynia in mice requires both the lectin-like and EGF-like domains.
Journal: Biochemical and biophysical research communications
Published: November 04, 2017
Role of Thrombin in Soluble Thrombomodulin-Induced Suppression of Peripheral HMGB1-Mediated Allodynia in Mice.
Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
Published: August 29, 2017
The effects of AP521, a novel anxiolytic drug, in three anxiety models and on serotonergic neural transmission in rats.
Journal: Journal of pharmacological sciences
Published: December 09, 2013
Post-marketing surveillance data of thrombomodulin alfa: sub-analysis in patients with sepsis-induced disseminated intravascular coagulation.
Journal: Journal of intensive care
Published: November 11, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026